HCHongLing Chu

HongLing Chu

*This is an algorithmically generated author record based on publicly available information.

HongLing Chu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and Initial Validation of Patient-reported Lumbar Surgery Quality of Life (LSQoL)

    by YuDong Zhao, Li Zhang, SiYu Zhou, ShengFeng Wang, JiaLiang Lin, Yu Jiang, YaNan Mei, ChunXia Zhao, HongBin He, HongLing Chu, et al.

    Study Design.: A mixed-methods study. Objective.: To develop and perform the initial validation of the Lumbar Surgery Quality of Life (LSQoL), a multidimensional patient-reported outcome measure for patients with lumbar degenerative diseases. Summary of background data.: Patient-reported outcome measures (PROMs) are widely used to evaluate outcomes in lumbar degenerative diseases but are often applied in combination, with each instrument capturing only specific aspects of patient status. Consequently, improvement in traditional measures such as the Oswestry Disability Index (ODI) does not always correspond to patient-perceived recovery or satisfaction, highlighting the need for multidimensional tools that better reflect patient experience. Methods.: The LSQoL was developed using a multistage mixed-method approach, including literature review, patient interviews, expert consensus through the Delphi method, and weighting via the Analytic Hierarchy Process (AHP). The instrument was validated in 1,996 patients with lumbar degenerative diseases. Internal consistency, test–retest reliability, construct validity, and correlations with established PROMs and patient-reported recovery and satisfaction were evaluated. Results.: The LSQoL consists of 21 items across five dimensions: pain, neurological function, activities of daily living, emotional status, and working ability. Internal consistency was acceptable to good (Cronbach’s α: 0.744–0.805), and test–retest reliability was strong (ICC: 0.759–0.906). Factor analyses supported a stable multidimensional structure. The LSQoL demonstrated moderate correlations with established PROMs and stronger correlations with patient-reported recovery and satisfaction. Conclusion.: The LSQoL is a reliable and valid PROM that provides a comprehensive assessment of quality of life in patients with lumbar degenerative diseases. It is suitable for evaluating patient-reported outcomes both before and after lumbar surgery.

  • 基于MRI前列腺腺体相关参数构建腹腔镜前列腺癌术后尿失禁的预测模型

    by Hai Mao, Fan Zhang, Zhan Yi Zhang, Ye Yan, Yi Chang Hao, Yi Huang, Lu Lin Ma, Hong Ling Chu, Shu Dong Zhang

    评估基于MRI前列腺腺体相关参数构建的列线图预测腹腔镜前列腺癌术后尿失禁的临床价值。 纳入经前列腺穿刺活检诊断为前列腺腺癌并于北京大学第三医院行腹腔镜根治性前列腺切除术(laparo-scopic radical prostatectomy,LRP)的202例患者,所有患者的术前MRI检查于前列腺穿刺活检术前1周内完成,腺体相关参数包含前列腺上下径、左右径、前后径、前列腺体积、前列腺尖部突入深度(intravesical prostatic protrusion length,IPPL)、前列腺尖部形态分型等。自术后第1个月起,每个月对患者的控尿功能恢复情况进行随访,以全天不需要使用尿垫作为控尿功能恢复标准。应用Logistic多因素回归分析影响术后早期控尿功能恢复的危险因素,绘制各模型预测术后控尿功能恢复的受试者操作特征(receiver operator characteristic,ROC)曲线,以DeLong检验比较曲线下面积的差异,以决策曲线分析评价模型的临床净获益。 202例患者的平均年龄为69.0(64.0, 75.5)岁,穿刺前平均前列腺特异性抗原(prostate specific antigen,PSA)为12.12 (7.36, 20.06) μg/L,穿刺Gleason评分 < 7分和≥7分者分别为73例(36.2%)和129例(63.9%),临床分期为T1/T2期者100例(49.5%),T3期者102例(50.5%)。经术前MRI测量,前列腺体积为35.4 (26.2, 51.1) mL,前列腺上下径与左右径的比值为0.91 (0.77, 1.07),膜性尿道长度为15 (11, 16) mm,IPPL为2 (0, 6) mm,前列腺尖部形态分型A~D型分别为67例(33.2%)、80例(39.6%)、24例(11.9%)和31例(15.3%),训练集和验证集分别为141例和61例。所有患者手术均顺利完成,随访3个月患者的控尿率为59.4%(120/202例)。训练集多因素分析结果显示,膜性尿道长度(P < 0.001)、IPPL(P=0.017)和临床分期(P=0.022)是术后早期(3个月)尿失禁发生的独立危险因素。根据多因素分析结果制作列线图和临床决策曲线,计算训练集ROC曲线下面积为0.885 (0.826, 0.944),计算验证集ROC曲线下面积为0.854 (0.757, 0.950)。在验证集里对模型进行Hosmer-Lemeshow拟合优度检验,卡方值为5.426 (P=0.711)。 术前膜性尿道长度、IPPL、临床分期是LRP术后早期尿失禁发生的独立危险因素,基于MRI前列腺腺体相关参数构建的列线图可有效预测LRP术后早期控尿功能恢复,但此结果还需更大规模的临床研究证实。


  • Open Access

    The effectiveness of percutaneous endoscopic decompression compared with open decompression and fusion for lumbar spinal stenosis: protocol for a multicenter, prospective, cohort study

    by Shuheng Zhai, Wenkui Zhao, Bin Zhu, Xin Huang, Chen Liang, Bao Hai, Lixiang Ding, Hongwei Zhu, Xianhai Wang, Feng Wei, et al.

    Background: Lumbar spinal stenosis (LSS) is one of the most frequent indications for spine surgery. Open decompression and fusion surgery was the most common treatment and used to be regarded as the golden standard treatment for LSS. In recent years, percutaneous endoscopic decompression surgery was also used for LSS. However, the effectiveness and safety of percutaneous endoscopic decompression in the treatment of LSS have not been supported by high-level evidence. Our aim is to 1) compare the effectiveness of percutaneous endoscopic decompression surgery and open decompression and fusion for the treatment of LSS. 2) Investigate the prognosis risk factors for LSS. 3) Evaluate the influence of percutaneous endoscopic decompression for the stability of operative level, and degeneration of adjacent level. Methods: It’s a prospective, multicenter cohort study. The study is performed at 4 centers in Beijing. This study plans to enroll 600 LSS patients (300 patients in the percutaneous endoscopic decompression group, and 300 patients in the open decompression and fusion group). The demographic variables, healthcare variables, symptom related variables, clinical assessment (Visual analogue score (VAS), Oswestry disability index (ODI), Japanese Orthopaedic Association score (JOA)), and radiological assessment (dynamic X-ray, CT, MRI) will be collected at baseline visit. Patients will follow up at 3, 6, 12 months. The primary outcome is the difference of improvement of ODI between baseline and 12-month follow-up between the two groups. The secondary outcome is the score changes of preoperative and postoperative VAS, the recovery rate of JOA, MacNab criteria, patient satisfaction, degeneration grade of adjacent level, ROM of operative level and adjacent level, complication rate. Discussion: In this study, we propose to conduct a prospective registry study to address the major controversies of LSS decompression under percutaneous spinal endoscopy, and investigate the clinical efficacy and safety of percutaneous endoscopic decompression and open decompression in the treatment of LSS. Trial registration: This study has been registered on clinicaltrials.gov in January 15, 2020 (NCT04254757). (SPIRIT 2a).